Gene · 341
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment. | BMC Bioinformatics | 2022 | 36175853 | PubTator, text mining | PubMed |
| Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease. | J Clin Endocrinol Metab | 2022 | 36173828 | PubTator, text mining | PubMed |
| Proteomics Combined with RNA Sequencing to Screen Biomarkers of Sepsis. | Infect Drug Resist | 2022 | 36172619 | PubTator, text mining | PubMed |
Interactive effects of the low-carbohydrate diet score and genetic risk score on Hypo-HDL-cholesterolemia among Korean adults: A cross-sectional analysis from the Ansan and Ansung Study of the Korean Genome and Epidemiology Study. | Food Sci Nutr | 2022 | 36171780 | PubTator, text mining | PubMed |
| Drug genetic associations with COVID-19 manifestations: a data mining and network biology approach. | Pharmacogenomics J | 2022 | 36171417 | PubTator, text mining | PubMed |
| The human host response to monkeypox infection: a proteomic case series study. | EMBO Mol Med | 2022 | 36169042 | PubTator, text mining | PubMed |
| Diabetic kidney disease in pediatric patients: A current review. | World J Diabetes | 2022 | 36159227 | PubTator, text mining | PubMed |
| Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma. | Front Oncol | 2022 | 36158683 | PubTator, text mining | PubMed |
| SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response. | Life Sci | 2022 | 36150465 | PubTator, text mining | PubMed |
| Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals. | Molecules | 2022 | 36144669 | PubTator, text mining | PubMed |
| Long-Lived Individuals Show a Lower Burden of Variants Predisposing to Age-Related Diseases and a Higher Polygenic Longevity Score. | Int J Mol Sci | 2022 | 36142858 | PubTator, text mining | PubMed |
| Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases. | Int J Mol Sci | 2022 | 36142794 | PubTator, text mining | PubMed |
| Apolipoproteins-New Biomarkers of Overweight and Obesity among Childhood Acute Lymphoblastic Leukemia Survivors? | Int J Mol Sci | 2022 | 36142534 | PubTator, text mining | PubMed |
| Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development. | Front Genet | 2022 | 36118876 | PubTator, text mining | PubMed |
| Comparison of single‑nucleus and single‑cell transcriptomes in hepatocellular carcinoma tissue. | Mol Med Rep | 2022 | 36111491 | PubTator, text mining | PubMed |
| The known unknowns of apolipoprotein glycosylation in health and disease. | iScience | 2022 | 36111253 | PubTator, text mining | PubMed |
| Plasma biomarkers and their correlation in adult children of parents with Alzheimer's disease. | Front Aging Neurosci | 2022 | 36110426 | PubTator, text mining | PubMed |
| Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma. | Exp Hematol Oncol | 2022 | 36109804 | PubTator, text mining | PubMed |
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. | Redox Biol | 2022 | 36108528 | PubTator, text mining | PubMed |
| [Dysfunctional high-density lipoproteins in diabetes mellitus]. | Probl Endokrinol (Mosk) | 2022 | 36104968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/341/papers?page=34